OraSure’s DNA Genotek subsidiary received FDA EUA for its ORAcollect-RNA saliva collection device for SARS CoV-2
On Nov. 3, 2020, OraSure Technologies announced its DNA Genotek subsidiary has received Emergency Use Authorization from the…
-
-
Penn Medicine birth marked a milestone in uterus transplant clinical trial
On Jan. 9, 2020, Penn Medicine announced the birth of Benjamin Thomas Gobrecht: his mother, 33-year-old Jennifer Gobrecht,…
-
Penn Medicine researchers received $97 million grant from the NIH to study traumatic brain injuries and neurodegeneration
On Oct. 24, 2019, Penn Medicine researchers received $9.7 million grant from the NIH to study traumatic brain…
-
Penn Medicine developed gene therapy to treat Duchenne muscular dystrophy (DMD
On Oct. 7, 2019, Penn Medicine announced it had developed gene therapy to treat Duchenne muscular dystrophy (DMD)…
-
Penn Medicine received $22 million from NIH HEAL Initiative to combat the national opioid crisis
On Oct. 4, 2019, Penn Medicine announced they had received $22 Million from National Institutes of Health’s (NIH)…
-
UPenn completed exclusive R&D alliance with Novartis
On Sept. 12, 2019, UPenn completed its exclusive, 7-year research and development alliance with Novartis, that spawned the…
-
Penn received a $12 million grant to study the connection between cellular therapies and new methods of radiation therapy
On Jun. 3, 2019, the University of Pennsylvania (Penn) announced it had received a $12 million grant from…
-
The National Cancer Institute awarded a $10.7 million grant to Abramson Cancer Center to study CAR T cells in solid tumors
On Oct. 22, 2018, the National Cancer Institute (NC) awarded a $10.7 million five year grant to Abramson…
-
First wine making was discovered
On. Nov. 13, 2017, research by Dr. Patrick McGovern, Director of the Biomolecular Archaeology Laboratory at the University…
-
University of Pennsylvania announced $1.5 billion Hospital Pavilion
On May 3, 2017, the University of Pennsylvania announced plans to build a $1.5 billion new hospital on…
-
Arbutus’ CSO, Dr. Michael J Sofia, awarded Lasker-DeBakey Clinical Medical Research Award
On Sept. 13, 2016, Arbutus Biopharma announced that Dr. Michael J. Sofia, Arbutus’ Chief Scientific Officer, had been…
-
The Parker Institute for Cancer Immunotherapy was founded
On Apr. 13, 2016, the Parker Institute for Cancer Immunotherapy was created with a $250 million grant from…
-
Bioject Medical Technologies was acquired by Inovio Pharmaceuticals
On Mar. 14, 2016, Inovio Pharmaceuticals announced an agreement to acquire all of Bioject Medical Technologies’ assets including…
-
Korff estate gifted $5 million to advance prostate cancer research and treatments in Nebraska
On Nov. 18, 2015, the estate of Glenn Korff gifted $5 million to the Fred & Pamela Buffett…
-
FDA approved quadrivalent formulation of Fluzone Intradermal inactivated influenza vaccine
On Dec. 12, 2014, Sanofi Pasteur announced the U.S. Food and Drug Administration (FDA) had approved the supplemental…
-
DNA was isolated from the deadly 1849 cholera outbreak in Philadelphia
On Jan. 9, 2014, DNA was isolated from a 165-year-old intestine of a cholera victim from Philadelphia – …
-
Matrical Bioscience acquired by Brooks Automation for $10 million
On Jul. 23, 2013, Matrical Bioscience announced it has had been acquired by Chelmsford, Massachusetts-based Brooks Automation for…
-
The Center for Personalized Diagnostics (CPD) was established at UPenn
In Feb. 2013, the Center for Personalized Diagnostics (CPD) was established at UPenn for researching genomic and therapeutic…
-
The Basser Center for BRCA was established at Penn Medicine’s Abramson Cancer Center
In 2012, the Basser Center for BRCA was established at Penn Medicine’s Abramson Cancer Center to establish a…
-
First international collaboration on Alzheimer’s disease genetics was launched
On Jan. 31, 2011, the first international collaboration on Alzheimer’s disease genetics was launched. The International Genomics of…
-
Phase III results for first HIV/AIDS (Aidsvax) vaccine reported
On Sept. 24, 2009, the second Phase III HIV-1 vaccine trial, also known as RV144, that began in…
-
Biotechnology | FDA | Polio | Vaccine
FDA licensed Sanofi Pasteur’s new pediatric combination vaccine, Pentacel
On Jun. 23, 2008, Sanofi Pasteur announced the U.S. Food and Drug Administration (FDA) had licensed Pentacel, Diphtheria…
-
CDC published updated recommendation for meningococcal vaccination of at-risk children age 2-10 years in MMWR
On Oct. 17, 2007, the Food and Drug Administration (FDA) approved quadrivalent meningococcal conjugate vaccine (MCV4) (Menactra®, Sanofi…
-
HHS awarded $132.5 million to Sanofi Pasteur and MedImmune over five years to retrofit existing domestic vaccine manufacturing facilities
On Jun. 14, 2007, the U.D. of Health and Human Services (HHS) awarded $132.5 million to Sanofi Pasteur…
-
FDA approved an accelerated dosing schedule for Twinrix (hepatitis A and B vaccine)
On Mar. 28, 2007, the U.S. Food and Drug Administration (FDA) announced that GlaxoSmithKline (King of Prussia, Pennsylvania)…
-
The CDC responded to a multi-state outbreak of E coli infections
On Dec. 14, 2006, the U.S. Centers for Disease Control and Prevention (CDC) reported a multi-state outbreak of…
-
HHS awarded a contract for $97 million to Sanofi Pasteur to develop cell culture-based influenza vaccines for the U.S.
On Apr. 1, 2005, Sanofi pasteur was awarded a five-year $97 million contract from the U.S. Department of…
-
Contracts awarded to Aventis Pasteur and Chiron to develop vaccine against H5N1 avian influenza virus
On May 27, 2004, the National Institute of Allergy and Infectious Diseases (NIAID) announced it had awarded contracts…
-
ACIP voted to withdraw their recommendation for rotavirus vaccine
On Oct. 22, 1999, the Advisory Committee on Immunization Practices (ACIP), after a review of scientific data from…
-
Wyeth Lederle Vaccines voluntarily withdrew Rotashield from the market
On Oct. 15, 1999, Wyeth-Lederle Vaccines announced that it was withdrawing the Rotashield vaccine from the market and…
